Zoghbi Huda Y Insider Trading Activity
Zoghbi Huda Y has been net-selling over the last 12 months with 0 purchases and 11 sales across 1 company.
REGN is the most-traded position with 11 trades. The largest single transaction was a sale of REGN for $258K on Feb 19, 2026.
Performance Scorecard
Forward stock performance after each transaction by Zoghbi Huda Y. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | +5.7% | 100% | 11 |
| 90 days | — | +16.8% | 100% | 11 |
| 120 days | — | — | — | — |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersREGN · REGENERON PHARMACEUTICALS, INC.
🔒 Subscribe to see trade entries
Pro members see exactly when Zoghbi Huda Y bought and sold REGN.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | ROLE |
|---|---|---|---|---|---|---|
| Feb 19, 2026 | REGN | Sell | 49 | $774.68 | $38K | Director |
| Feb 19, 2026 | REGN | Sell | 50 | $775.50 | $39K | Director |
| Feb 19, 2026 | REGN | Sell | 53 | $778.47 | $41K | Director |
| Feb 19, 2026 | REGN | Sell | 208 | $779.55 | $162K | Director |
| Feb 19, 2026 | REGN | Sell | 331 | $780.45 | $258K | Director |
| Feb 19, 2026 | REGN | Sell | 209 | $781.28 | $163K | Director |
| Feb 19, 2026 | REGN | Sell | 298 | $782.10 | $233K | Director |
| Feb 19, 2026 | REGN | Sell | 220 | $783.29 | $172K | Director |
| Feb 19, 2026 | REGN | Sell | 160 | $784.45 | $126K | Director |
| Feb 19, 2026 | REGN | Sell | 56 | $785.61 | $44K | Director |
| Feb 19, 2026 | REGN | Sell | 4 | $790.00 | $3K | Director |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| REGN | REGENERON PHARMACEUTICALS, INC. | 11 | $1.3M |
Other insiders at REGENERON PHARMACEUTICALS, INC.
3 other tracked filers at REGN.